Nanotechnology Now - News Story: Owlstone sale generates Ł2.2m investment

Home > News > Owlstone sale generates Ł2.2m investment

July 19th, 2010

Owlstone sale generates Ł2.2m investment

Abstract:
A $3.3m (Ł2.2m) investment has been secured by nanotechnology company Owlstone through the sale of shares from its US-based business Owlstone Nanotech.

Source:
theengineer.co.uk

Bookmark:

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Sensors

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Homeland Security

The picture of health: Virginia Tech researchers enhance bioimaging and sensing with quantum photonics June 30th, 2023

Sensors developed at URI can identify threats at the molecular level: More sensitive than a dog's nose and the sensors don't get tired May 21st, 2021

UCF researchers generate attosecond light from industrial laser: The ultrafast measurement of the motion of electrons inside atoms, molecules and solids at their natural time scale is known as attosecond science and could have important implications in power generation, chemical- August 25th, 2020

Highly sensitive dopamine detector uses 2D materials August 7th, 2020

Military

Single atoms show their true color July 5th, 2024

NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE